Enabling independence and enriching community engagement for all individuals with DS.

Empowering families to learn, share, and connect
Catalyzing a clinical network that delivers transformational results
Identifying and accelerating high impact research

Your Donation Helps

Down syndrome research offers opportunities for people of all ages with Down syndrome. Your support is essential to finding safe, effective drugs and interventions to improve health and independence. Your gift is crucial to furthering these breakthroughs.

We’ve designed a clear path to therapies

Based on recent scientific findings, our CEO, board and world renowned scientific advisors have established four priorities for funding research. We’re focused on exciting research targeting the root cause with the objective of improving health and independence for our loved ones throughout their lifetimes. Our four priorities are: preventing Alzheimer’s onset, improving cognition, developing gene therapies, and advancing understanding.

LuMind RDS News

Under one roof: LuMind Research Down Syndrome Foundation and Massachusetts Down Syndrome Congress work together for the Down syndrome community

BURLINGTON, MA — (October 22, 2018) — LuMind™ Research Down Syndrome Foundation (LuMind RDS) and Massachusetts Down Syndrome Congress (MDSC) are now neighbors working together for the greater good. On October 1, LuMind RDS moved its headquarters to Burlington – in the same building where MDSC has been headquartered since 2011. This move provides new …

Read More

LuMind Research Down Syndrome Foundation relocates to Burlington, MA

BURLINGTON, Ma—(October 22, 2018)—Local nonprofit organization, LuMind Research Down Syndrome Foundation (LuMind RDS), opened its new office at 20 Burlington Mall Road in Burlington, Massachusetts on October 15, 2018. The foundation, which focuses on results-driven Down syndrome research, is relocating from Marlborough, Massachusetts, where it has been headquartered the last 4 years. To celebrate, LuMind …

Read More

What people are saying about us.

“I never thought I would be in a position to say, ‘We are going to take therapies forward to directly treat Down syndrome.’ Now I think that is the case. We really are in the early stages of a revolution in understanding the basis for many of the features that occur in Down syndrome.”

Dr. Roger Reeves, Johns Hopkins